Abstract
Endoscopic injection sclerotherapy has proven to be effective in reducing the severity of bleeding from esophageal varices in cirrhotic patients. However, rebleeding occurs in certain patients, and this can affect their long-term survival. Therefore, to evaluate varices that were likely to rebleed, the relationship between esophageal variceal re-bleeding and endoscopic variceal findings at the time of the initial injection scierotherapy were investigated, in cirrhotic patients. Sixty-three patients were investigated; they were assigned to three groups according to their Child's classification: A, B, and C. After the initial scierotherapy, rebleeding occurred in 14 patients (22%), specifically in 5% of those in group A, in 16% of those in group B, and in 47% of those in group C. The endoscopie findings at the time of the initial scierotherapy revealed that redness of the varices was most intense in the group C patients. Patients in whom the varices were intensely red and/or were located up to the level of the tracheal bifurcation were found to be the most likely to rebleed. Therefore, to prevent rebleeding in patients manifesting these signs, careful monitoring and repeated endoscopie injection scierotherapy is recommended.
Similar content being viewed by others
References
Matloff DS (1991) Treatment of acute variceal bleeding. Gastroenterol Clin Nor Am 21:103–118
Terblanche J, Bornman PC, Kahn D, Jonker MAT, Campbell HAH, Wright J, Kirsch R (1983) Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. Lancet 2:1328–1332
Burroughs AK, McCormick PA (1992) Prevention of variceal rebleeding. Gastroenterol Clin Nor Am 21:119–147
Rossi V, Cales P, Burtin P, Charneah J, Person B, Pujol P, Valntin S, D'Aubigny N, Joubaud F, Boyer J (1991) Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: Prospective controlled trial of propranolol and sclerotherapy. J Hepatol 12:283–289
Pugh RNH, Murray-Lyon IM, Dawson JD, Pietroni HC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649
Takase Y, Ozaki A, Orii K, Nagoshi K, Okamura T, Iwasaki Y (1982) Injection sclerotherapy of esophageal varices for patients undergoing emergency and elective surgery. Surgery 92:474–479
Japanese Research Society for Portal Hypertension (1980) The general rules for recording endoscopic findings in esophageal varices. Jpn J Surg 10:84–87
Crafoord C, Frenckner P (1939) New surgical treatment of varicose veins of esophagus. Acta Otolaryngol 27:422–429
Moersch HJ (1940) The treatment of esophageal varices by injection of a sclerosing solution. J Thorac Cardiovasc Surg 10:300–309
Kapp F, Buess HJ (1973) Osophaguswand-sklerosierung als Therapie bluten der Osophagusvarizen bel inoerablen Patienten. Dtsch Med Wochenschr 98:2465–2469
Sauerbruch T, Weinzierl M, Ansari H, Baumgartener G (1987) Injection sclerotherapy of oesophageal variceal haemorrhage. A prospective long-term follow-up study. Endoscopy 19:181–184
Hashizume M, Kitano S, Yamaga H, Wada H, Sugimachi K (1990) Eradication of oesophageal varices recurring after portal non-decompressive surgery by injection sclerotherapy. Br J Surg 77:940–943
Author information
Authors and Affiliations
About this article
Cite this article
Uchiyama, K., Takada, T., Yasuda, H. et al. Markers of potential esophageal variceal rebleeding in cirrhotic patients undergoing endoscopic injection sclerotherapy. J Hep Bil Pancr Surg 1, 168–171 (1994). https://doi.org/10.1007/BF01222243
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01222243